Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • PMC Free PDF
  • Publisher Full Text
  • Authors
  • Abdo AA
  • Lee SS
  • MESH
  • Antiviral Agents
  • Disease Progression
  • Fatty Liver
  • Genotype
  • Hepacivirus
  • Hepatitis C
  • Humans
  • Insulin Resistance

Unbound MEDLINE

Hepatitis C, insulin resistance and fatty liver: bad things come in threes.

Links

  • PMC Free PDF
  • Publisher Full Text

    • Authors

    Abdo AA, Lee SS

    Source

    Canadian journal of gastroenterology = Journal canadien de gastroenterologie 26:6 2012 Jun pg 323

    MeSH

    Antiviral Agents
    Disease Progression
    Fatty Liver
    Genotype
    Hepacivirus
    Hepatitis C
    Humans
    Insulin Resistance

    Pub Type(s)

    Editorial
    Introductory Journal Article

    Language

    eng

    PubMed ID

    22720271

    Related Citations

    • Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.
    • Emerging therapies for hepatitis C virus (HCV) infection: the importance of HCV genotype.
    • Genotype III - HCV infection.
    • Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C.
    • [Steatosis and hepatitis C].
    • PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection.
    • Super-infection with genotype 4 hepatitis C virus in a patient treated for genotype 3 acute hepatitis C.
    • Hepatitis C and steatosis.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved